Skip to main content

NIEHS Awards Caliper Knockout Mouse Model Contract Worth Up To $7M

NEW YORK (GenomeWeb News) - Caliper Life Sciences said today that it has received a contract from the National Institutes of Environmental Health Services valued at up to $7 million to develop customized transgenic and knockout mouse models though its Xenogen Biosciences business.
 
The company said the contract will begin immediately and could run up to 10 years “at the option of NIEHS.” The contract was awarded to Caliper through a competitive bid process.
 
Caliper said the NIEHS will use the genetically modified mouse models as part of its research to identify and possibly prevent hazardous conditions and exposure in humans.
 
Caliper said it has made over 9,000 unique mouse and rat models, some of which have already been supplied to the NIEHS through a previous multi-year agreement.
 
Xenogen is the in vivo pharmaceutical drug-discovery branch of Caliper Discovery Alliances & Services.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.